ID | Name | Number of studies | |
---|---|---|---|
CL_0000624 | CD4-positive, alpha-beta T cell | 48 | |
CL_0000934 | CD4-positive, alpha-beta cytotoxic T cell | 8 |
Gene | Number of supported studies | Average coverage | Other major groups (express this gene) | Other cell types (express this gene) | |
---|---|---|---|---|---|
CXCR6 | 3 | 25% ± 4% | 0 | 9 | |
PRF1 | 4 | 32% ± 14% | 0 | 21 | |
IFNG | 3 | 19% ± 3% | 0 | 11 | |
LAG3 | 3 | 28% ± 11% | 0 | 12 | |
CD5 | 3 | 28% ± 7% | 0 | 20 | |
CD6 | 3 | 37% ± 11% | 0 | 24 | |
ZAP70 | 3 | 34% ± 12% | 0 | 27 | |
GZMM | 3 | 43% ± 8% | 0 | 27 | |
GZMA | 6 | 58% ± 25% | 1 | 26 | |
GNLY | 4 | 41% ± 10% | 1 | 20 | |
SLAMF1 | 3 | 28% ± 10% | 1 | 10 | |
KLRB1 | 4 | 37% ± 16% | 1 | 26 | |
CD3G | 4 | 51% ± 17% | 1 | 29 | |
CD3D | 5 | 60% ± 31% | 2 | 34 | |
TNFRSF18 | 3 | 40% ± 13% | 2 | 15 | |
CD2 | 5 | 61% ± 28% | 2 | 35 | |
TNFRSF4 | 3 | 48% ± 8% | 2 | 15 | |
BATF | 3 | 43% ± 8% | 2 | 23 | |
LCK | 4 | 54% ± 28% | 2 | 34 | |
CD247 | 4 | 39% ± 20% | 2 | 34 | |
CD96 | 3 | 31% ± 9% | 2 | 33 | |
SELPLG | 3 | 36% ± 23% | 2 | 34 | |
CD3E | 5 | 72% ± 29% | 3 | 37 | |
SKAP1 | 4 | 34% ± 11% | 3 | 35 | |
GIMAP7 | 4 | 33% ± 17% | 3 | 41 | |
ITGAL | 3 | 35% ± 7% | 3 | 36 | |
CST7 | 5 | 67% ± 26% | 4 | 36 | |
NKG7 | 5 | 62% ± 28% | 4 | 40 | |
CCL5 | 4 | 57% ± 22% | 4 | 33 | |
CD69 | 6 | 47% ± 6% | 4 | 54 |
GO_0045190 | Biological process | isotype switching |
GO_0002841 | Biological process | negative regulation of T cell mediated immune response to tumor cell |
GO_0002903 | Biological process | negative regulation of B cell apoptotic process |
Cell type name | CD4-positive, alpha-beta cytotoxic T cell |
Synonyms | CD4-positive alpha-beta cytotoxic T lymphocyte CD4-positive alpha-beta cytotoxic T-cell CD4-positive alpha-beta cytotoxic T-lymphocyte |
Description | A CD4-positive, alpha-beta T cell that has cytotoxic function. |
Parent | CL_0000624 |